Cargando…
Home Use of Mini-Dose Glucagon As a Novel Treatment for Hypoglycemia Following Repeated, Prolonged Fasts in Type 1 Diabetes During Ramadan
OBJECTIVE: We determined the efficacy of self-administered subcutaneous mini-dose glucagon (MDG) to treat fasting-induced hypoglycemia in type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS: This was a 4-week randomized, controlled crossover trial of 2-week MDG or 2-week oral glucose tablets (OG, con...
Autores principales: | Algeffari, Metab, Hussain, Sufyan, Almogbel, Turki, Alsharidah, Mansour, Alghadouni, Habibah, Mahmood, Farid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016730/ https://www.ncbi.nlm.nih.gov/pubmed/35176134 http://dx.doi.org/10.2337/dc21-1655 |
Ejemplares similares
-
Rosuvastatin-Induced Oral Ulcer: A Case Report and Review of Literature
por: Algeffari, Metab, et al.
Publicado: (2022) -
Real-Time Continuous Glucose Monitoring Significantly Reduces Severe Hypoglycemia in Hypoglycemia-Unaware Patients With Type 1 Diabetes
por: Choudhary, Pratik, et al.
Publicado: (2013) -
Natural Language Processing Improves Detection of Nonsevere Hypoglycemia in Medical Records Versus Coding Alone in Patients With Type 2 Diabetes but Does Not Improve Prediction of Severe Hypoglycemia Events: An Analysis Using the Electronic Medical Record in a Large Health System
por: Misra-Hebert, Anita D., et al.
Publicado: (2020) -
Cambridge Hybrid Closed-Loop System in Very Young Children With Type 1 Diabetes Reduces Caregivers’ Fear of Hypoglycemia and Improves Their Well-being
por: de Beaufort, Carine, et al.
Publicado: (2022) -
Evolution of Abnormal Plasma Glucagon Responses to Mixed-Meal Feedings in Youth With Type 1 Diabetes During the First 2 Years After Diagnosis
por: Sherr, Jennifer, et al.
Publicado: (2014)